Cardiology ≈ CardiologyCardiology
View article: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Open
status: Published
View article
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Open
peer reviewed
View article
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association Open
Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports on the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health …
View article
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes Open
In the time-to-event analysis, the rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among patients with type 2 diabetes mellitus was lower with liraglutide than with place…
View article
2018 ESC/EACTS Guidelines on myocardial revascularization Open
International audience
View article
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes Open
Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, \nwhether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharm…
View article
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Open
BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding…
View article
2016 European Guidelines on cardiovascular disease prevention in clinical practice Open
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at \nthe time of their publication.
View article
2017 ESC/EACTS Guidelines for the management of valvular heart disease Open
Mathematical support for phonocardiographic signal processing has been developed based on a mathematical model in the form of a periodically correlated stochastic process and a component processing method. On the basis of mathematical supp…
View article
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Open
In patients with type 2 diabetes who were at high cardiovascular risk, the rate of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke was significantly lower among patients receiving semaglutide than among those recei…
View article
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Open
Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health. These guidelines, which …
View article
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Open
In patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease, treatment with dapagliflozin did not result in a higher or lower rate of MACE than placebo but did result in a lower rate of cardiovascula…
View article
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Open
he ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of …
View article
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association Open
Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health beh…
View article
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease Open
In our trial, inhibition of PCSK9 with evolocumab on a background of statin therapy lowered LDL cholesterol levels to a median of 30 mg per deciliter (0.78 mmol per liter) and reduced the risk of cardiovascular events. These findings show …
View article
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct Open
Among patients with acute stroke who had last been known to be well 6 to 24 hours earlier and who had a mismatch between clinical deficit and infarct, outcomes for disability at 90 days were better with thrombectomy plus standard care than…
View article
2021 ESC/EACTS Guidelines for the management of valvular heart disease Open
International audience
View article
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients Open
In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke. (Funded by Edwards Lifesciences; PARTNER 2 ClinicalTrials.gov number, NCT01314313.).
View article
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Open
A correction has been published: European Heart Journal, ehaa895, https://doi.org/10.1093/eurheartj/ehaa895
View article
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure Open
Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure than those in the placebo group, regardless of the presence or a…
View article
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging Open
Endovascular thrombectomy for ischemic stroke 6 to 16 hours after a patient was last known to be well plus standard medical therapy resulted in better functional outcomes than standard medical therapy alone among patients with proximal mid…
View article
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients Open
Among patients with severe aortic stenosis who were at low surgical risk, the rate of the composite of death, stroke, or rehospitalization at 1 year was significantly lower with TAVR than with surgery. (Funded by Edwards Lifesciences; PART…
View article
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Open
Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should f…
View article
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) Open
Myocardial injury is significantly associated with fatal outcome of COVID-19, while the prognosis of patients with underlying CVD but without myocardial injury is relatively favorable. Myocardial injury is associated with cardiac dysfuncti…
View article
Empagliflozin in Heart Failure with a Preserved Ejection Fraction Open
Empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes. (Funded by Boehringer…
View article
Haemodynamic definitions and updated clinical classification of pulmonary hypertension Open
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent d…
View article
2023 ESC Guidelines for the management of acute coronary syndromes Open
peer reviewed
View article
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel Open
Consistent evidence from numerous and multiple different types of clinical and genetic studies unequivocally establishes that LDL causes ASCVD.
View article
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients Open
In patients with severe aortic stenosis who were at low surgical risk, TAVR with a self-expanding supraannular bioprosthesis was noninferior to surgery with respect to the composite end point of death or disabling stroke at 24 months. (Fun…
View article
Global Disparities of Hypertension Prevalence and Control Open
Background: Hypertension is the leading preventable cause of premature death worldwide. We examined global disparities of hypertension prevalence, awareness, treatment, and control in 2010 and compared secular changes from 2000 to 2010. Me…